Search | Clinical Trials Finder

Conditions: Iron-deficiency Anemia (IDA), Pregnancy
Interventions: daily ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill, alternate day ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill; Drug
Lead sponsor: Southern Illinois University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Springfield, Illinois

Conditions: Pregnancy Related, Anemia, Iron Deficiency
Interventions: Ferumoxytol Injection [Feraheme], Ferrous Sulfate; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Stanford, California

Conditions: Chronic Kidney Insufficiency, Chronic Kidney Diseases
Interventions: Ferrous Sulfate; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 1 Year to 21 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 2
States / cities: New York, New York • Philadelphia, Pennsylvania

Conditions: Anemia, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: darbepoetin alfa, ferrous sulfate, sodium ferric gluconate complex in sucrose, placebo; Biological · Dietary Supplement · Drug + 1 more
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 502 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 2
States / cities: Scottsdale, Arizona • Rochester, Minnesota

Conditions: Anemia
Interventions: Ferric Carboxymaltose (FCM), Ferrous Sulfate tablets; Drug
Lead sponsor: American Regent, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 456 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Norristown, Pennsylvania

Conditions: Anemia, Iron Deficiency, Heavy Menstrual Bleeding
Interventions: Ferumoxytol, Ferrous Sulfate; Drug
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Autosomal Dominant Hypophosphatemic Rickets
Interventions: Iron; Dietary Supplement
Lead sponsor: Indiana University; Other
Eligibility: 25 Months and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Iron Deficiency
Interventions: Fer-In-Sol (ferrous sulfate), Iron fortified cereal; Dietary Supplement
Lead sponsor: National Institutes of Health (NIH); NIH
Eligibility: 1 Month to 24 Months
Enrollment: 171 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2005
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Iron Deficiency Anemia of Pregnancy
Interventions: Ferrous Sulfate; Dietary Supplement
Lead sponsor: UConn Health; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Chronic Kidney Disease, Iron-deficiency Anemia
Interventions: IV Iron, Ferrous Sulfate; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Iron Deficiency Anaemia, Chronic Kidney Disease
Interventions: FCM (Ferric carboxymaltose) high ferritin target, FCM (Ferric carboxymaltose) low ferritin target, Oral Iron (Ferrous sulphate); Drug
Lead sponsor: Vifor Pharma; Industry
Eligibility: 18 Years and older
Enrollment: 626 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Wilmington, North Carolina

Conditions: Non-anemic Iron Deficiency
Interventions: Ferrous sulfate, Prenatal, Docusate Sodium, Ascorbic Acid 500Mg Tab, Placebo; Drug
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 3
States / cities: Bohemia, New York • Commack, New York • East Setauket, New York

Conditions: Iron Bioavailability
Interventions: Control Porridge, Reference Porridge A, Test Porridge B, Test Porridge C, Test Porridge D; Other
Lead sponsor: Purdue University; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Failure With Preserved Ejection Fraction (HFPEF), Iron Deficiency, Iron-deficiency Anemia (IDA)
Interventions: Ferric Carboxymaltose, Ferrous Sulfate; Drug
Lead sponsor: Syed Hamza Mufarrih; Other
Eligibility: 18 Years to 100 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Bowling Green, Kentucky

Conditions: Iron Deficiency Anemia
Interventions: Ferrous Sulfate; Dietary Supplement
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 64 Years · Female only
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Anemia
Interventions: Ferrous Sulfate tablets, Ferric Carboxymaltose (FCM); Drug
Lead sponsor: American Regent, Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 255 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Norristown, Pennsylvania

Conditions: Iron Deficiency Anemia of Pregnancy
Interventions: Ferrous sulfate 325mg, Ferumoxytol; Dietary Supplement · Drug
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Iron
Interventions: Ferrous sulfate, IHAT, Aspiron, Placebo; Dietary Supplement · Other
Lead sponsor: Tufts University; Other
Eligibility: 50 Years to 80 Years
Enrollment: 226 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Anemia, Iron-Deficiency, Kidney Failure, Chronic
Interventions: Sodium Ferric Gluconate Complex in Sucrose Injection, Ferrous sulfate tablets; Drug
Lead sponsor: Watson Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 23
States / cities: Tucson, Arizona • Los Angeles, California • Palo Alto, California + 20 more

Conditions: Erythropoietic Protoporphyria, EPP, X-linked Protoporphyria, XLP
Interventions: Oral Iron; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 6
States / cities: Birmingham, Alabama • San Francisco, California • New York, New York + 3 more

Conditions: Very Low Birth Weight Infant, Premature Infants, Anemia of Prematurity, Iron Deficiency, Anaemia in Children, Extremely Low Birth Weight
Interventions: 6 mg/kg of oral iron as ferrous sulfate administered every other day., 6 mg/kg of oral iron as ferrous sulfate administered every day.; Dietary Supplement
Lead sponsor: CHRISTUS Health; Other
Eligibility: 26 Weeks to 32 Weeks
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Anemia
Interventions: Oral iron tablets, VIT-45; Drug
Lead sponsor: American Regent, Inc.; Industry
Eligibility: Female only
Enrollment: 361 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Norristown, Pennsylvania

Conditions: Anemia
Interventions: Oral Iron, sodium ferric gluconate; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 8
States / cities: Hot Springs, Arkansas • Orange County, California • Simi Valley, California + 5 more

Conditions: ADHD, Iron-deficiency, Restless Legs Syndrome, Periodic Limb Movement Sleep Disorder
Interventions: ferrous sulfate; Dietary Supplement
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 5 Years to 18 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

Oral Iron Supplementation on Alternate vs. Consecutive Days for Iron Deficiency Anemia in Pregnancy

Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia

Oral Iron in Children With Chronic Kidney Disease

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding

IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding

Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.

Iron and the Breast-Fed Infant: Iron Status and Two Regimens of Iron Supplementation

Daily vs Intermittent Iron Therapy in Pregnancy

A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease

Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)

Treatment of Non-Anemic Iron Deficiency in Pregnancy

Iron Bioavailability From Cereal-based Foods

IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches

Daily vs Alternate Day Iron Supplementation for Pregnant Women With Iron Deficiency Anemia

VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy

Safe and Effective Delivery of Supplemental Iron to Healthy Volunteers

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients

Oral Iron for Erythropoietic Protoporphyrias

Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)

Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum Anemia

Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.

Impact of Iron Supplementation Treatment on Brain Iron Concentrations